Introducing Invokana, the generic for Canagliflozin, Anti‑Diabetes Tablets – a selective SGLT2 inhibitor formulated to reduce blood glucose by enhancing urinary glucose excretion. It supports weight loss and improves metabolic control, resulting in better glycemic balance. Experience efficient diabetes management and improved cardiovascular outcomes with this innovative, targeted therapy for optimal long‑term care.